Abstract

Small cationic peptides radiolabeled with technetium-99m are new tools for the scintigraphic imaging of bacterial infections. Due to the specific binding of these peptides to the bacterial membrane, they accumulate at sites of infection but not in sterile inflammatory lesions, This article describes the characteristics of these peptides and the available labeling methods to tag these compounds with technetium-99m, the radionuclide of choice fot future human use. Results for the mapping of experimental infections in mice and monitoring the efficacy of antibacterial therapy are also presented. Technetium-99m-labeled cationic antimicrobial peptides, thus, are promising candidates for the scintigraphic visualization of sites of bacterial infection in patients.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.